No Concurrent Contraindication Between Fluconazole (Diflucan) and Acyclovir
There is no contraindication to using fluconazole (Diflucan) and acyclovir concurrently. These medications can be safely administered together, though one specific interaction requires awareness.
Key Drug Interaction
The FDA label for Diflucan does not list acyclovir as a contraindicated medication 1. The only documented interaction is pharmacokinetic in nature:
- Atovaquone levels are decreased when coadministered with acyclovir 2
- This interaction is relevant only if a patient is taking atovaquone (an antiprotozoal) alongside both fluconazole and acyclovir
- Fluconazole increases atovaquone concentrations, while acyclovir decreases them 2
Clinical Evidence Supporting Concurrent Use
Real-world clinical experience demonstrates safe concurrent administration:
- A case report documented successful treatment of combined herpetic and candidal esophagitis using intravenous acyclovir and fluconazole together in a CAPD patient 3
- The patient's symptoms improved with this combination therapy
- No adverse drug interactions were reported between these two agents
Guideline Support for Combination Therapy
Multiple infectious disease guidelines recommend concurrent antifungal and antiviral prophylaxis in immunocompromised patients:
- HSV/VZV prophylaxis with acyclovir (400-800 mg PO twice daily) can be continued alongside fluconazole for Candida prophylaxis in HIV-infected patients receiving cancer therapy 4
- Guidelines for HIV-exposed children recommend acyclovir for herpes simplex prophylaxis without restrictions regarding concurrent azole antifungal use 5
Practical Considerations
When prescribing both medications:
- No dose adjustments are required for either drug
- Standard monitoring for each medication's individual adverse effects should continue
- Fluconazole's extensive CYP450 interactions (CYP2C9, CYP2C19, CYP3A4) do not involve acyclovir, which is primarily renally eliminated 1
- Both medications require renal dose adjustment in kidney dysfunction, but this is independent of their co-administration
The only scenario requiring caution is the three-drug combination of fluconazole + acyclovir + atovaquone, where therapeutic drug monitoring of atovaquone may be warranted due to opposing effects on its metabolism 2.